7901 - 7925 of 8808 Results
Title
Year
-
OPENTitle: The role of autophagy in synucleinopathy: clearance versus spread of α-synucleinJournal Name: Autophagy ReportsPublisher: Informa UK LimitedVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1080/27694127.2025.2577406Best OA location URL: https://doi.org/10.1080/27694127.2025.2577406Citation Count: 0
-
OPENTitle: Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI)Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 201End Page: 209Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.12.025Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8978879Citation Count: 21
-
OPENTitle: Subthalamic nucleus—sensorimotor cortex functional connectivity in de novo and moderate Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 462End Page: 469Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2014.07.004Best OA location URL: http://doi.org/10.1016/j.neurobiolaging.2014.07.004Citation Count: 47
-
OPENTitle: Genome-wide meta-analysis of short-tandem repeats for Parkinson’s disease risk using genotype imputationJournal Name: Brain CommunicationsPublisher: Oxford University Press (OUP)Vol: 6Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/braincomms/fcae146Best OA location URL: https://academic.oup.com/braincomms/advance-article-pdf/doi/10.1093/braincomms/fcae146/57311805/fcae146.pdfCitation Count: 2
-
OPENTitle: Aromaticity at position 39 in α‐synuclein: A modulator of amyloid fibril assembly and membrane‐bound conformationsJournal Name: Protein SciencePublisher: WileyVol: 31Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/pro.4360Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/pro.4360Citation Count: 9
-
OPENTitle: The protective effect of LRRK2 p.R1398H on risk of Parkinson's disease is independent of MAPT and SNCA variantsJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 35Issue #: 1Start Page: 266.e5End Page: 266.e14Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2013.07.013Best OA location URL: https://www.sciencedirect.com/science/article/pii/S0197458013003187Citation Count: 38
-
OPENTitle: Upregulating β-hexosaminidase activity in rodents prevents α-synuclein lipid associations and protects dopaminergic neurons from α-synuclein-mediated neurotoxicityJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-01004-6Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-020-01004-6Citation Count: 19
-
OPENTitle: Portrait of blood-derived extracellular vesicles in patients with Parkinson’s diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 124Issue #:Start Page: 163End Page: 175Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2018.11.002Best OA location URL: https://doaj.org/article/8d8cf4f9837744e3b7e12b8b5fafeecfCitation Count: 43
-
RESTRICTEDTitle: Autophagy activation ameliorates cognitive deficits and alpha-synuclein pathology in an adeno-associated viral vector mediated rat model of Lewy body disordersJournal Name: Pharmacology Biochemistry and BehaviorPublisher: Elsevier BVVol: 257Issue #:Start Page: 174096End Page: 174096Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pbb.2025.174096Citation Count: 0
-
OPENTitle: Monitoring PARKIN RBR Ubiquitin Ligase Activation States with UbFluorJournal Name: Current Protocols in Chemical BiologyPublisher: WileyVol: 10Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cpch.45Citation Count: 6
-
RESTRICTEDTitle: Nanoparticle standards for immuno-based quantitation of α-synuclein oligomers in diagnostics of Parkinson's disease and other synucleinopathiesJournal Name: Clinica Chimica ActaPublisher: Elsevier BVVol: 466Issue #:Start Page: 152End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.cca.2017.01.010Citation Count: 27
-
OPENTitle: Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel StudyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-025-01008-wBest OA location URL: https://www.nature.com/articles/s41531-025-01008-w.pdfCitation Count: 0
-
OPENTitle: Effects of LRRK2 Inhibitors on Nigrostriatal Dopaminergic NeurotransmissionJournal Name: CNS Neuroscience & TherapeuticsPublisher: WileyVol: 23Issue #: 2Start Page: 162End Page: 173Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/cns.12660Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/cns.12660Citation Count: 28
-
OPENTitle: The anti-parkinsonian drug zonisamide reduces neuroinflammation: Role of microglial Nav 1.6Journal Name: Experimental NeurologyPublisher: Elsevier BVVol: 308Issue #:Start Page: 111End Page: 119Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2018.07.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7404626Citation Count: 38
-
RESTRICTEDTitle: Assessment of Wearing Off in Parkinson’s disease using objective measurementJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 268Issue #: 3Start Page: 914End Page: 922Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-020-10222-wCitation Count: 21
-
OPENTitle: Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 64Issue #:Start Page: 79End Page: 87Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2013.12.011Best OA location URL: https://doi.org/10.1016/j.nbd.2013.12.011Citation Count: 81
-
OPENTitle: Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human BrainJournal Name: Journal of Proteome ResearchPublisher: American Chemical Society (ACS)Vol: 16Issue #: 9Start Page: 3336End Page: 3347Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jproteome.7b00324Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5698003Citation Count: 55
-
OPENTitle: Neuroimaging and clinical predictors of fatigue in Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 23Issue #:Start Page: 45End Page: 49Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.11.029Best OA location URL: http://doi.org/10.1016/j.parkreldis.2015.11.029Citation Count: 36
-
OPENTitle: Probabilistic Modelling of Gait for Robust Passive Monitoring in Daily LifeJournal Name: IEEE Journal of Biomedical and Health InformaticsPublisher: Institute of Electrical and Electronics Engineers (IEEE)Vol: 25Issue #: 6Start Page: 2293End Page: 2304Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1109/jbhi.2020.3037857Best OA location URL: https://doi.org/10.1109/jbhi.2020.3037857Citation Count: 18
-
RESTRICTEDTitle: A Phase 2a study of nilotinib in patients with advanced and early Parkinson’s disease. Study design (P5.068)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 90Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.90.15_supplement.p5.068Citation Count: 0
-
OPENTitle: Tissue engineered nigrostriatal pathway for treatment of Parkinson's diseaseJournal Name: Journal of Tissue Engineering and Regenerative MedicinePublisher: WileyVol: 12Issue #: 7Start Page: 1702End Page: 1716Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/term.2698Best OA location URL: https://europepmc.org/articles/pmc6416379?pdf=renderCitation Count: 58
-
OPENTitle: Diffusion tensor imaging of the nigrostriatal fibers in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 30Issue #: 9Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26251Best OA location URL: http://doi.org/10.1002/mds.26251Citation Count: 106
-
OPENTitle: Nilotinib – Differentiating the Hope from the HypeJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 6Issue #: 3Start Page: 519End Page: 522Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-160904Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd160904?id=journal-of-parkinsons-disease%2Fjpd160904Citation Count: 29
-
OPENTitle: Network connectivity and local transcriptomic vulnerability underpin cortical atrophy progression in Parkinson’s diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 40Issue #:Start Page: 103523End Page: 103523Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2023.103523Best OA location URL: https://doi.org/10.1016/j.nicl.2023.103523Citation Count: 14
-
OPENTitle: Asymptomatic carriers of the p.A53T SNCA mutation: Data from the PPMI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 98Issue #:Start Page: 72End Page: 74Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.04.001Citation Count: 2